Why cancer incidence increases with age — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/02/140203155042.htm
source : http://www.sciencedaily.com/releases/2014/02/140203155042.htm
source : http://www.sciencedaily.com/releases/2014/01/140130121611.htm
source : http://www.sciencedaily.com/releases/2014/01/140130102044.htm
The landscape of genetic testing has broadened to include a range of diseases, and demand for testing and counseling has greatly increased because of direct-to-consumer marketing, says the study’s lead investigator, Marc Schwartz, PhD, co-leader of Georgetown Lombardi’s Cancer Prevention and Control Program. "It’s important that all people interested in testing have access to thorough information so they can consider the implications of test results and interpret them in the context of family history," says Schwartz, who is also co-leader of the Fisher Center for Familial Cancer Research at Georgetown. "Counseling on the phone reduces costs and expands genetic counseling and testing access to rural areas, where counseling isn’t always available." While this study was conducted with women considering testing for mutations in the breast or ovarian cancer genes BRCA1 and/or BRCA2, the findings "may extend to genetic counseling for other hereditary cancers and complex conditions in adults such as heart disease," says co-author Beth N. …
The team, led by Nichola Garbett, Ph.D., published its findings online today in PLOS ONE. …
"It has been considered that the upturn in cases of lung cancer is possibly related to this particles," explains Patricia Gorocica from the INER, who, alongside her research team, has been working in an alternative therapy to boost the immune system of patients with this disease. The specialist adds that since several years ago is known that the immune system has all the mechanism to watch and destroy tumor cells as they develop, but sometimes this mechanisms are not effective for reasons associated to the tumor or alterations of the patients organism. Based in this principle, research at INER is directed to regulate the immune system against tumors. …
Toward a new generation of screening tests An increasing number of genetic mutations have been identified as risk factors for the development of cancer and many other diseases. Several research groups have attempted to develop rapid and inexpensive screening methods for detecting these mutations. "The results of our study have considerable implications in the area of diagnostics and therapeutics," says Professor Francesco Ricci, "because the DNA clamp can be adapted to provide a fluorescent signal in the presence of DNA sequences having mutations with high risk for certain types cancer. …
The researchers published their findings, "Silencing of RB1 and RB2/p130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation," in the Feb. 1, 2014, issue (online Nov. 25) of the journal Cell Cycle…
Eight of the nine boys registered to date in the new trial are alive and well, with functioning immune systems and free of infections associated with SCID-X1, between nine and 36 months following treatment, according to Sung-Yun Pai, MD, a pediatric hematologist-oncologist from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. …
Now, researchers from MIT and Brigham and Women’s Hospital (BWH) have developed a new type of nanoparticle that can be delivered orally and absorbed through the digestive tract, allowing patients to simply take a pill instead of receiving injections. In a paper appearing in the Nov. 27 online edition of Science Translational Medicine, the researchers used the particles to demonstrate oral delivery of insulin in mice, but they say the particles could be used to carry any kind of drug that can be encapsulated in a nanoparticle…